Guillain-barré syndrome (GBS) with antecedent chikungunya infection: a case report and literature review
-
Published:2024-04-11
Issue:1
Volume:6
Page:
-
ISSN:2524-3489
-
Container-title:Neurological Research and Practice
-
language:en
-
Short-container-title:Neurol. Res. Pract.
Author:
V. Sreelakshmi, Pattanaik AmritaORCID, Marate Srilatha, Mani Reeta S, Pai Aparna R., Mukhopadhyay Chiranjay
Abstract
AbstractGuillain-Barré Syndrome (GBS) is an autoimmune neuropathy. Antecedent infections have been seen to be significant triggering factors for developing GBS. Among them, arboviral infections are rapidly gaining importance as significant triggers, especially in the areas where they are endemic. Chikungunya, an arboviral infection that usually causes a self-limiting acute febrile illness can lead to GBS as one its severe complications. Herein, we describe a case of a 21-year-old female who presented with weakness in all four limbs and paresthesia. Nerve conduction study and cerebrospinal fluid (CSF) analysis showed axonal, demyelinating motor and sensory neuropathy with albuminocytological dissociation indicating Acute Motor and Sensory Axonal Neuropathy (AMSAN) variant of GBS. Serum IgM antibodies against ganglioside GM1 were detected. Anti-Chikungunya IgM antibodies were found in both serum and CSF samples. The patient was initiated with Intravenous Immunoglobulin (IVIG) therapy. In view of hypoxia, she was intubated and was on mechanical ventilation. After 2 weeks of being comatose, the patient gradually improved and was discharged with no sequelae.A literature review on antecedent infections in GBS is presented alongside the case report to better understand the association of GBS with antecedent infections, especially the endemic arboviral infections like Chikungunya, Dengue and Zika. This will help in reinforcing the significance of having robust surveillance and public health control measures for infectious diseases.
Publisher
Springer Science and Business Media LLC
Reference84 articles.
1. Bragazzi, N. L., Kolahi, A. A., Nejadghaderi, S. A., Lochner, P., Brigo, F., Naldi, A., et al. (2021). Global, regional, and national burden of Guillain–Barré syndrome and its underlying causes from 1990 to 2019. J Neuroinflammation, 18(1), 264. https://doi.org/10.1186/s12974-021-02319-4. 2. Kuwabara, S. (2004). Guillain-Barré syndrome: Epidemiology, pathophysiology and management. Drugs, 64(6), 597–610. https://doi.org/10.2165/00003495-200464060-00003. 3. Zheng, P., Tian, D. C., Xiu, Y., Wang, Y., & Shi, F. D. (2021). Incidence of Guillain-Barré syndrome (GBS) in China: A national population-based study. The Lancet Regional Health Western Pacific, 18, 100302. https://doi.org/10.1016/j.lanwpc.2021.100302. 4. Matsui, N., Nodera, H., Kuzume, D., Iwasa, N., Unai, Y., et al. (2018). Guillain-Barré syndrome in a local area in Japan, 2006–2015: An epidemiological and clinical study of 108 patients. European Journal of Neurology, 25(5), 718–724. https://doi.org/10.1111/ene.13569. 5. Mathew, T., Srinivas, M., Nadig, R., Arumugam, R., & Sarma, G. R. (2014). Seasonal and monthly trends in the occurrence of Guillain-Barre syndrome over a 5-year period: A tertiary care hospital-based study from South India. Annals of Indian Academy of Neurology, 17(2), 239–241. https://doi.org/10.4103/0972-2327.132662.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|